The EDA rewrites its drug-pricing rulebook around costs, competition, and localization
The new framework ties repricing to FX, inflation, and interest rates while introducing new rules for originators, generics, biosimilars, and…
Available in your choice of English or Arabic
The new framework ties repricing to FX, inflation, and interest rates while introducing new rules for originators, generics, biosimilars, and…
Regulatory wins are opening new markets for drugmakers, but forced pricing and thin financing still cap how fast exports can…
Good morning, everyone. Digitizing, standardizing, and localizing are all on deck in today’s issue. Overland freight is moving toward digitization.…
PLUS: Egypt completes its side of the Egypt-Syria Business Council ahead of reconstruction push
The EDA will roll out a new pricing system that prices locally made meds at 50-60% of import equivalents, and…
PLUS: Gov’t orders asset freezes, travel bans for Global Paradigm School owner
The raise that lifted Future Care onto the main board was earmarked for this all along — a sterilization-products factory…
Producers are increasing insulin capacity to serve new export customers in Europe and Africa, but releases abroad remain tied to…
Something went wrong. Please refresh the page and/or try again.
Queue